232
Views
13
CrossRef citations to date
0
Altmetric
Original Research

A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer

, , ORCID Icon, , ORCID Icon, , & ORCID Icon show all
Pages 1995-2019 | Published online: 25 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jian Yang, Yong Hu, Lu Wang, Xiangran Sun, Ling Yu & Weichun Guo. (2021) Human umbilical vein endothelial cells derived-exosomes promote osteosarcoma cell stemness by activating Notch signaling pathway. Bioengineered 12:2, pages 11007-11017.
Read now

Articles from other publishers (11)

Hossein Abolhassani, Alireza Eskandari, Anita Saremi Poor, Ali Zarrabi, Behnoosh Khodadadi, Sara Karimifard, Hamidreza Sahrayi, Mahsa Bourbour & Mohammad Tavakkoli Yaraki. (2024) Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models. Coordination Chemistry Reviews 508, pages 215754.
Crossref
Pei-Hua Chuang, Bor-Show Tzang, Chih-Chen Tzang, Chun-Ching Chiu, Chun-Yu Lin & Tsai-Ching Hsu. (2024) Impact of oseltamivir on the risk of cancer. Frontiers in Oncology 14.
Crossref
Nityanand Srivastava, Salman Sadullah Usmani, Rajasekaran Subbarayan, Rashmi Saini & Pranav Kumar Pandey. (2023) Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens. Frontiers in Oncology 13.
Crossref
Suwei Dong, Yanbin Xiao, Ziqiang Zhu, Xiang Ma, Zhuohui Peng, Jianping Kang, Jianqiang Wang, Yunqing Wang & Zhen Li. (2023) Metformin sensitises osteosarcoma to chemotherapy <em>via</em> the IGF-1R/miR-610/FEN1 pathway. European Journal of Histochemistry 67:2.
Crossref
David A. Bunsick, Jenna Matsukubo & Myron R. Szewczuk. (2023) Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform. Cancers 15:4, pages 1030.
Crossref
Nádia Calvo Martins Okuyama, Diego Luís Ribeiro, Claudia Quintino da Rocha, Érica Romão Pereira, Ilce Mara de Syllos Cólus & Juliana Mara Serpeloni. (2023) Three-dimensional cell cultures as preclinical models to assess the biological activity of phytochemicals in breast cancer. Toxicology and Applied Pharmacology 460, pages 116376.
Crossref
Bessi Qorri, Reza Bayat Mokhtari, William W. Harless & Myron R. Szewczuk. (2022) Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression. Cancers 14:6, pages 1374.
Crossref
Batool Mousavi-Koodehi, Leila Darzi, Majid Sadeghizadeh, Farhood Najafi & Mehdi Forouzandeh-Moghdam. (2022) Replacement of hydrochloride in metformin hydrochloride with caprylic acid to investigate its effects on MCF-7 and MDA-MB-231 breast cancer cell lines. Life Sciences 293, pages 120308.
Crossref
Yufei Liu, Long Yang, Guijing Chen, Zhentao Liu, Tao Lu, Yong Yang, Jia Yu, Dongdong Kang, Wei Yan, Min He, Shuhao Qin, Jie Yu, Chuan Ye & Heng Luo. (2021) PBAT hollow porous microfibers prepared via electrospinning and their functionalization for potential peptide release. Materials & Design 207, pages 109880.
Crossref
Hamendra Singh Parmar, Aakruti Nayak, Pramod Kumar Gavel, Hem Chandra Jha, Shivani Bhagwat & Rajesh Sharma. (2021) Cross Talk between COVID-19 and Breast Cancer. Current Cancer Drug Targets 21:7, pages 575-600.
Crossref
Yi Wen, Yundi Chen, Guosheng Wang, Komal Abhange, Fei Xue, Zachary Quinn, Wenjun Mao & Yuan Wan. (2020) Factors influencing the measurement of the secretion rate of extracellular vesicles. The Analyst 145:17, pages 5870-5877.
Crossref